Malalignment, Bone, Osteoarthritis, Knee
Conditions
Keywords
knee osteotomy, MAT, meniscal allograft transplatation
Brief summary
This is a prospective randomized double-blind controlled clinical trial with parallel arms and 1:1 allocation. The main objective of the BIOMAT project is to demonstrate, through an RCT, whether the combined approach by knee osteotomy and MAT can provide clinical improvement over knee osteotomy alone for the treatment of patients with monocompartmental knee OA associated with meniscal insufficiency and lower extremity malalignment. Secondary objectives are to demonstrate whether the addition of MAT to knee osteotomy in patients with monocompartmental OA can improve biomechanical parameters and whether this treatment has protective effects on the joint environment and cartilage degeneration.
Detailed description
Patients with single-compartment arthritic pathology of the knee, axial deviation and meniscal deficit, for whom a surgical indication of corrective osteotomy is placed, will be recruited into the study. Enrollment takes place during hospitalization and is by the physician. All patients will undergo a knee osteotomy to achieve proper alignment of the lower limb and an arthroscopic procedure to macroscopically verify the status of the cartilage and menisci, with associated minor procedures for surgical cleanup when necessary. After intraoperative confirmation of inclusion criteria (complete meniscal deficit and absence of severe articular cartilage impairment) all patients will undergo synovial biopsy and synovial fluid sampling, half of the patients will also undergo arthroscopic homologous meniscus transplantation. Clinical, biomechanical and biological evaluations will be performed: Clinical evaluation of the patient will be done through validated questionnaires before surgery and at 1-3-6-12 months. These will document subjective clinical improvement, functional measurements, and imaging using radiographs as per clinical practice and MRI. Pitch Analysis will be used for biomechanical assessments, and will be performed before surgery and at 12-month follow-up after surgery for all patients enrolled in the two groups. basal inflammation will be assessed on synovial tissue and synovial fluid samples collected after intraoperative confirmation of patient inclusion criteria (complete meniscal deficit and absence of severe articular cartilage impairment). Serum/plasma and urine samples will be collected before surgical treatment and at 1-3-6-12 months follow-up.
Interventions
PROCEDUREKnee osteotomy associated with meniscal allograft transplantation
Patients will undergo knee osteotomy associated with meniscal allograft transplantation, which will be implanted by arthroscopic technique with body fixation by all-inside and transosseous sutures to the posterior horn and if necessary to the anterior horn.
PROCEDUREKnee osteotomy
Knee osteotomy
Sponsors
Istituto Ortopedico Rizzoli
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)
Masking description
Clinical evaluations will be carried out by medical personnel not involved in treatment to ensure double-blinding
Intervention model description
Parallel Assignment
Eligibility
Sex/Gender
ALL
Age
20 Years to 60 Years
Healthy volunteers
No
Inclusion criteria
1. Male or female patients aged between 20 and 60 years; 2. Single-compartment tibiofemoral osteoarthritis (Kellgren-Lawrence grade ≤ 3); 3. Surgical indication of corrective osteotomy (axial deviation of lower extremities \> 5°); 4. Meniscal deficit of the compartment affected by the overload due to malalignment; 5. Ability and consent of patients to actively participate in the rehabilitation protocol and clinical and radiological follow-up (RX and MRI) 6. Signature of informed consent
Exclusion criteria
1. Patients who are incapacitated or have neurological disorders that may invalidate the research protocol; 2. Diagnosis of neoplastic diseases; 3. Diagnosis of rheumatoid arthritis, Reiter's syndrome, psoriatic arthritis, gout, ankylosing spondylitis or arthritis resulting from another inflammatory disease; human immunodeficiency virus (HIV) infection, viral hepatitis; chondrocalcinosis; 4. Patients with uncontrolled diabetes mellitus; 5. Patients with uncontrolled thyroid metabolic disorders; 6. Patients abusing alcoholic beverages, drugs or medications; 7. Body Mass Index \> 40; 8. Pregnancy or lactation status or intention to become pregnant during the period of study participation; 9. Patients undergoing knee surgery in the previous 12 months.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| IKDC-Subjective Score (Subjective International Knee Documentation Committee) | 12 months follow-up | This is a subjective, knee-specific rating scale that is considered one of the most reliable assessment tools in the evaluation of knee pathology. The questionnaire examines 3 categories: symptoms, sports activity, and knee function |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| WOMAC (Western Ontario and McMaster Universities Osteoarthritis Index) score | baseline, 1 month, 3 months, 6 months and 12 months follow-up | It's a standardized and widely used questionnaire to assess the condition of patients with knee OA and includes assessment of pain, stiffness and physical function of the joints. It can be administered to the patient. It measures 5 items for pain (range 0-20), two for stiffness (range 0-8), and 17 for functional limitation (range 0-68) that mainly relate to activities of daily living (e.g., getting up from a sitting position, bending over, going up and down stairs etc.); the score is then normalized on a 0-100 scale. Higher values indicated a worse outcome. |
| KOOS Score ( Knee Injury and Osteoarthritis Outcome score) | baseline, 1 month, 3 months, 6 and 12 months follow-up | The full questionnaire consists of five subscales and they cover: pain (9 items), symptoms (7 items of which two relate to stiffness), functions and activities of daily living (17 items) physical function, sports activities and leisure (5 items) and quality of life in relation to the knee (4 items). All items in the relevant subscales have the same response mode, use a 5-point Likert scale, and each question is assigned a score from 0 to 4, where 0 indicates no difficulty and 4 a severe difficulty). Score range 0-100 for each subscale |
| VAS-dolore (Visual Analogue Scale) | baseline, 1 month, 3 months, 6 and 12 months follow-up | Visual analog scale consisting of a straight line segment (10 cm length), the ends of which correspond to no pain and the strongest pain imaginable. |
| EQ-VAS | baseline, 1 month, 3 months, 6 and 12 months follow-up | Visual analog scale consisting of a straight line segment (10 cm length), the ends of which correspond to no pain and the strongest pain imaginable. |
| Tegner Activity Level Scale | baseline, 1 month, 3 months, 6 and 12 months follow-up | It is a questionnaire to find out the patient's level of physical activity. |
| IKDC-Subjective Score (Subjective International Knee Documentation Committee) | baseline, 1 month, 3 months and 6months follow-up | This is a subjective, knee-specific rating scale that is considered one of the most reliable assessment tools in the evaluation of knee pathology. The questionnaire examines 3 categories: symptoms, sports activity, and knee function |
| WORMS (Whole-Organ Magnetic Resonance Imaging Score) | baseline, 12 months follow-up | It's a semiquantitative, multifunctional scoring method for knee assessment applicable to conventional MRI techniques. |
| Kellgren-Lawrence score | baseline, 1 month, 6 months, 12 months follow-up. | The Kellgren Lawrence scale classifies knee OA into 4 grades of subsequent greater severity, the parameters used being reduced joint space and the presence of osteophytes |
| Biomechanical analysis | baseline, 12 months follow-up | Collection of three-dimensional spatial motion data using a 9-camera stereophotogrammetric system combined with wireless 16-channel electromyograph and two force platforms for monitoring foot-ground reaction force. The acquired data will be used to estimate joint rotations and moments, spatiotemporal data, electromyography, and dynamometric data. |
| Biological assessments | Baseline (pre-operative), 24 hours, 1 month, 3 months, 6 months, 12 months | Synovial tissue and fluid samples will be collected after intraoperative confirmation of patient inclusion criteria (complete meniscal deficit and absence of severe articular cartilage impairment). Synovial tissue will be fixed, included and analyzed by immunohistochemistry methods for synovitis analysis using a standardized synovitis analysis score (IMSYC). Synovial fluid will be divided into aliquots and stored at -80°C. Inflammatory factors will be analyzed by enzyme immunoassays. Serum/plasma and urine samples will be collected from all patients included in the study at the indicated time points. |
| Final treatment opinion | 6 and 12 months follow-up | The patient should indicate satisfaction and relative degree with treatment at the end of the clinical trial (24 months follow-up). All patients will be able to indicate their health condition by choosing from this answers; Full recovery, much better, somewhat better, no change, a little worse, much worse. |
Countries
Italy
Contacts
Primary ContactAlessandro Di Martino, MD
Backup ContactRoberta Licciardi, MSc
Outcome results
None listed